Logo-apb
Submitted: 14 Oct 2024
Revision: 11 Feb 2025
Accepted: 05 Mar 2025
ePublished: 09 Mar 2025
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Adv Pharm Bull. Inpress.
doi: 10.34172/apb.43882
  Abstract View: 16

Research Article

Small T Oncoprotein of Merkel Cell Polyomavirus Attenuates Cisplatin-Induced Apoptosis and Enhances E1, E6/E7, MMP-1, and Ki-67 Expression in HeLa Cervical Cancer Cells

Fatemeh Pakdel ORCID logo, Seyed Masoud Hosseini ORCID logo, Neda Soleimani ORCID logo, Ali Farhadi* ORCID logo
*Corresponding Author: Email: farhadi_a@sums.ac.ir

Abstract

Purpose: Cervical cancer (CxCa), is mainly caused by high-risk human papillomaviruses (hrHPV), which disrupt the regulation of p53 and pRb, leading to uncontrolled cell growth and cancer progression. Co-infection with human polyomaviruses like MCPyV has been observed in some HPV-positive cases, suggesting a potential combined effect on tumor development. Cisplatin is commonly used for advanced CxCa, but resistance, often due to p53 disruption, remains a significant challenge. challenge. This study investigates if MCPyV sT oncoprotein, together with HPV-18 oncoproteins, affects the transcription of key genes, influencing cell proliferation and cisplatin resistance in CxCa. Methods: The sT gene was cloned into the pCMV6 vector and introduced into E. coli DH5α cells. HeLa cells were transfected with pCMV6-sT using Lipofectamine 3000. Transfection efficiency was assessed using fluorescence microscopy and flow cytometry. Protein expression was analyzed by SDS-PAGE and Western blotting. Cytotoxicity was measured with the MTT assay, gene expression was analyzed by RT-qPCR, Ki-67 staining was performed on cell blocks, and cisplatin-induced effects on cell proliferation and apoptosis were examined. Results: Cytotoxicity assays showed a significant increase in cell viability at 0.2 μg of sT plasmid after 72 hours (13.76%, P < 0.05). MCPyV sT expression significantly upregulated the mRNA levels of E1 (4.22-fold), E6/E7 (3.80-fold), and MMP1 (6-fold) (P < 0.001). Increased Ki-67 positivity, indicated enhanced cell proliferation. Additionally, sT expression reduced cisplatin-induced apoptosis, with fewer apoptotic cells observed in the sT + cisplatin group compared to the cisplatin-only group (25.9% vs. 38.3%, P < 0.05). Conclusion: The simultaneous presence of MCPyV sT and HPV oncoproteins enhances resistance to cisplatin-induced apoptosis in cervical cancer cells, necessitating further investigation into viral oncoprotein interactions to overcome therapeutic resistance.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 17

Your browser does not support the canvas element.


PDF Download: 0

Your browser does not support the canvas element.